Mathew NT - Search Results

1

Quantifying the return of headache in triptan-treated migraineurs: an observational study.

Sheftell F, Almas M, Weeks R, Mathew NT, Pitman V, Lipton RB. Sheftell F, et al. Among authors: mathew nt. Cephalalgia. 2010 Jul;30(7):838-46. doi: 10.1177/0333102409354390. Epub 2010 Mar 17. Cephalalgia. 2010. PMID: 20647175 Clinical Trial.

2

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group. Silberstein SD, et al. Headache. 2007 Feb;47(2):170-80. doi: 10.1111/j.1526-4610.2006.00684.x. Headache. 2007. PMID: 17300356 Clinical Trial.

3

Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.

Lipton RB, Silberstein S, Dodick D, Cady R, Freitag F, Mathew N, Biondi DM, Ascher S, Olson WH, Hulihan J. Lipton RB, et al. Cephalalgia. 2011 Jan;31(1):18-30. doi: 10.1177/0333102410372427. Epub 2010 May 17. Cephalalgia. 2011. PMID: 20974598 Clinical Trial.

4

Office-based treatment of acute migraine with dihydroergotamine mesylate.

Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, Silberstein SD, Solomon S. Winner P, et al. Headache. 1993 Oct;33(9):471-5. doi: 10.1111/j.1526-4610.1993.hed3309471.x. Headache. 1993. PMID: 8262792

5

Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.

Silberstein S, Lipton R, Dodick D, Freitag F, Mathew N, Brandes J, Bigal M, Ascher S, Morein J, Wright P, Greenberg S, Hulihan J. Silberstein S, et al. Headache. 2009 Sep;49(8):1153-62. doi: 10.1111/j.1526-4610.2009.01508.x. Headache. 2009. PMID: 19719543 Clinical Trial.

6

Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.

Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, Silberstein SD, Solomon S. Winner P, et al. Am J Emerg Med. 1994 Mar;12(2):138-41. doi: 10.1016/0735-6757(94)90232-1. Am J Emerg Med. 1994. PMID: 8161382 Clinical Trial.

7

Allodynia-associated symptoms, pain intensity and time to treatment: predicting treatment response in acute migraine intervention.

Cady RK, Freitag FG, Mathew NT, Elkind AH, Mao L, Fisher AC, Biondi DM, Finlayson G, Greenberg SJ, Hulihan JF. Cady RK, et al. Among authors: mathew nt. Headache. 2009 Mar;49(3):350-63. doi: 10.1111/j.1526-4610.2009.01340.x. Epub 2009 Feb 11. Headache. 2009. PMID: 19220503 Clinical Trial.

8

Early treatment of migraine with rizatriptan: a placebo-controlled study.

Mathew NT, Kailasam J, Meadors L. Mathew NT, et al. Headache. 2004 Jul-Aug;44(7):669-73. doi: 10.1111/j.1526-4610.2004.04125.x. Headache. 2004. PMID: 15209688 Clinical Trial.

9

Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).

Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L, Wright P, Greenberg SJ; AEGIS Investigator Study Group. Mathew NT, et al. Headache. 2007 Feb;47(2):189-98. doi: 10.1111/j.1526-4610.2006.00686.x. Headache. 2007. PMID: 17300358 Clinical Trial.

10

A long-term open-label study of oral almotriptan 12.5 mg for the treatment of acute migraine.

Mathew NT; Oral Almotriptan Study Group. Mathew NT, et al. Headache. 2002 Jan;42(1):32-40. doi: 10.1046/j.1526-4610.2002.02011.x. Headache. 2002. PMID: 12005273 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

169 results

Search Page

Filters